Skip to main content

Table 1 Demographic and clinical characteristics at baseline of participants by study group

From: Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial

  bCBT (n = 45) CAU (n = 43)
Characteristic n (%) n (%)
Age
 Mean (SD) 58.0 (11.3) 59.7 (10.0)
Gender
 Male 21 (46.7%) 20 (46.5%)
Education
 Low (ISCED 0–2) 11 (24.4%) 18 (41.9%)
 Middle (ISCED 3–5) 19 (42.2%) 10 (23.3%)
 High (ISCED 6–8) 15 (33.3%) 15 (34.9%)
Employment status
 Paid Employment 17 (37.8%) 17 (39.5%)
 Unemployed 8 (17.8%) 5 (11.6%)
 Voluntary work 4 (8.9%) 8 (18.6%)
 Retired 16 (35.6%) 14 (32.6%)
Primary cancer site
 Breast 18 (40.0%) 18 (41.9%)
 Colorectal 12 (26.7%) 10 (23.3%)
 Prostate 15 (33.3%) 15 (34.9%)
Treatment type
 Surgery 18 (40.0%) 11 (25.6%)
 Radiotherapy 0 (0.0%) 3 (7.0%)
 Surgery + Radiotherapy 9 (20.0%) 9 (20.9%)
 Surgery + Chemotherapy 12 (26.7%) 9 (20.9%)
 Surgery + Radiotherapy + Chemotherapy 6 (13.3%) 11 (25.6%)
Time since diagnosis (years)
 Mean (SD) 2.4 (1.5) 2.8 (1.3)
Time since last treatment (years)
 Mean (SD) 1.9 (1.5) 2.1 (1.4)
Number of comorbid diseases
 0 19 (42.2%) 14 (32.6%)
 1–2 19 (42.2%) 22 (51.2%)
 3+ 7 (15.6%) 7 (16.3%)
Psychological help in the past
 yes 22 (50.0%) 26 (60.5%)
  1. Abbreviations: bCBT blended cognitive behaviour therapy, CAU care as usual, ISCED International Standard Classification of Education, SD standard deviation